During the past decade, Aomori Prefectural Central Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aomori Prefectural Central Hospital" #1 sponsor was "Celgene" with 4 trials, followed by "Japan Clinical Cancer Research Organization" with 2 trials sponsored, "Kyowa Kirin Co., Ltd." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "BeiGene" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aomori Prefectural Central Hospital" #1 collaborator was "Japan Blood Products Organization" with 1 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator, "Kyowa Kirin, Inc." with 1 trials as a collaborator and "NPO International TRI Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Aomori Prefectural Central Hospital" are "Gastric Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Primary Myelofibrosis" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Aomori Prefectural Central Hospital" in a lesser frequency.

Most popular intervention types in "Aomori Prefectural Central Hospital" are "Drug" (12 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bendamustine" (2 trials), "Bortezomib" (2 trials), "Daratumumab" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aomori Prefectural Central Hospital" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aomori Prefectural Central Hospital". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Aomori Prefectural Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aomori Prefectural Central Hospital, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".